These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 826228)

  • 21. [Intensive supportive therapy in malignant hematologic diseases].
    Torlontano G
    Recenti Prog Med; 1975 Oct; 59(4):388-401. PubMed ID: 769107
    [No Abstract]   [Full Text] [Related]  

  • 22. [Advances in the treatment of acute leukemia in adults].
    Pawelski S
    Acta Haematol Pol; 1973; 4(4):283-9. PubMed ID: 4772918
    [No Abstract]   [Full Text] [Related]  

  • 23. Infections in leukaemia.
    Lancet; 1977 Jun; 1(8025):1294-5. PubMed ID: 68388
    [No Abstract]   [Full Text] [Related]  

  • 24. [Breakthrough in hematology?].
    Reizenstein P
    Lakartidningen; 1974 Aug; 71(32):2925-8. PubMed ID: 4605540
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical data on the efficiency of thrombocyte and granulocyte transfusion in acute leukemia].
    Kamanabroo D; Büchner T; Urbanitz D; Balleisen L; van de Loo J
    Med Welt; 1982 Dec; 33(51-52):1861-3. PubMed ID: 7162407
    [No Abstract]   [Full Text] [Related]  

  • 26. [Blood component therapy. Supportive therapy for acute leukemia (author's transl)].
    Maekawa I; Sakurada K; Shiraishi T
    Hokkaido Igaku Zasshi; 1977 Jul; 52(4):381-6. PubMed ID: 336501
    [No Abstract]   [Full Text] [Related]  

  • 27. [Substitution and protective therapy with blood components].
    Dietzfelbinger H; Woitinas F
    Med Klin; 1979 May; 74(18):680-5. PubMed ID: 431481
    [No Abstract]   [Full Text] [Related]  

  • 28. [Combination chemotherapy with cytosine arabinoside and daunomycin in childhood acute leukemia].
    Tsukimoto I; Mimaya J; Toyosaka H; Nagao T; Hanawa Y
    Rinsho Ketsueki; 1973 May; 14(5):596-603. PubMed ID: 4738276
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
    Malpas J; Mathé G; Hayat M
    Bull Cancer; 1974; 61(3):411-8. PubMed ID: 4533741
    [No Abstract]   [Full Text] [Related]  

  • 30. Combination of liposomal daunorubicin (DaunoXome), fludarabine, and cytarabine (FLAD) in patients with poor-risk acute leukemia.
    Clavio M; Venturino C; Pierri I; Garrone A; Miglino M; Canepa L; Balleari E; Balocco M; Michelis GL; Ballerini F; Gobbi M
    Ann Hematol; 2004 Nov; 83(11):696-703. PubMed ID: 15322763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Granulocyte transfusions from G-CSF-stimulated donors for the treatment of severe infections in neutropenic pediatric patients with onco-hematological diseases.
    Cesaro S; Chinello P; De Silvestro G; Marson P; Picco G; Varotto S; Pittalis S; Zanesco L
    Support Care Cancer; 2003 Feb; 11(2):101-6. PubMed ID: 12560938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of infections in immunocompromised cancer patients.
    Bajetta E; Gasparini G; Monfardini S; Volonterio A; Buzzoni R; Shinde S
    Haematologica; 1984; 69(5):576-97. PubMed ID: 6437936
    [No Abstract]   [Full Text] [Related]  

  • 33. Selective transfusion of blood components.
    McCredie KB
    Int Adv Surg Oncol; 1981; 4():145-71. PubMed ID: 7019094
    [No Abstract]   [Full Text] [Related]  

  • 34. [Quadruple combination chemotherapy of acute leukemia using daunomycin, cytosine arabinoside, 6-mercaptopurine riboside and prednisolone].
    Hirano M; Morita A; Sako F; Uetani T; Koie K
    Rinsho Ketsueki; 1972 Dec; 13(6):951-7. PubMed ID: 4675066
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of hemorrhagic incidents in acute leukemia and bone marrow aplasia. Personal results 1974-1981].
    Huart JJ; Jouet JP; Bauters F; Goudemand M
    Nouv Rev Fr Hematol (1978); 1983; 25(4):229-33. PubMed ID: 6622249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial.
    Pedersen-Bjergaard J; Brincker H; Ellegaard J; Drivsholm A; Freund L; Jensen KB; Jensen MK; Nissen NI
    Cancer Treat Rep; 1984 Oct; 68(10):1233-8. PubMed ID: 6597002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anthracyclines in the treatment of acute nonlymphocytic leukemias.
    Boiron M; Jacquillat C; Marty M; Weil M; Gisselbrecht C
    Cancer Treat Rep; 1981; 65 Suppl 4():73-6. PubMed ID: 6955013
    [No Abstract]   [Full Text] [Related]  

  • 38. Bone marrow failure: current concepts of pathophysiology and management.
    Epstein RB
    Surg Annu; 1978; 10():53-72. PubMed ID: 416509
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of infection in patients with acute leukemia.
    Wade JC
    Hematol Oncol Clin North Am; 1993 Feb; 7(1):293-315. PubMed ID: 8449863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacterial infections in the compromised host with special emphasis on patients with hematologic malignancies.
    Madhavan T
    Compr Ther; 1984 Jan; 10(1):19-24. PubMed ID: 6692667
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.